Company Filing History:
Years Active: 2012
Title: Innovations of Wen-bin Ho in HIF Hydroxylase Activity Inhibition.
Introduction
Wen-bin Ho is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit HIF hydroxylase activity. His work is crucial for advancing treatments related to hypoxia and related conditions.
Latest Patents
Wen-bin Ho holds a patent for "Chromene derivatives and use thereof as HIF hydroxylase activity inhibitors." This invention relates to novel compounds capable of decreasing HIF hydroxylase activity, thereby increasing the stability and/or activity of hypoxia-inducible factor (HIF). This patent represents a significant advancement in therapeutic strategies for diseases associated with hypoxia.
Career Highlights
Wen-bin Ho is currently employed at Fibrogen, Inc., where he continues to innovate and develop new therapeutic solutions. His expertise in biochemistry and pharmacology has positioned him as a key player in the research and development of novel compounds.
Collaborations
Wen-bin has collaborated with notable colleagues, including Lee Robert Wright and Shaojiang Deng. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Wen-bin Ho's contributions to the field of biochemistry, particularly through his patent on HIF hydroxylase activity inhibitors, highlight his innovative spirit and dedication to advancing medical science. His work at Fibrogen, Inc. continues to pave the way for new therapeutic options.